COMPANY PROFILE

TriVirum

Explore full profile

Reating affordable, medical-grade sensors offering actionable insights for clinicians

Lincoln, United StatesFounded 2018Health Tech & Medtech

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About TriVirum

Trivirum, Inc. is an early-stage medical device company that leverages cutting-edge semiconductor and signal processing technology to develop innovative medical devices. The company focuses on creating cost-effective, high-quality sensors that provide clinicians with actionable information to improve patient health outcomes while reducing costs for health plans. Trivirum serves healthcare providers and clinicians who require reliable and economically feasible clinical workflows for widespread deployment. Operating in the medical device market, Trivirum's business model revolves around the development and sale of advanced medical sensors and devices. The company generates revenue through the sale of these devices to healthcare institutions and clinics, aiming to address the needs of vulnerable populations at risk for serious health events. The founders of Trivirum bring decades of experience and a proven track record in medical device development, ensuring the company's products meet the highest standards of quality and innovation.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2018
Headquarters: Lincoln, United States
Employees: 1
Open positions: None listed
Dealroom signal: 57.6/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Health Diagnostics, Wearable, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Jan 2024	$9.1M	$36M	Undisclosed	↗
SEEDEquity / VC	Jun 2023	$9.1M	$36M	Undisclosed	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

TriVirum website traffic

Latest recorded traffic for TriVirum is 90 monthly website visits, down 70% over the last three months. TriVirum's team declined 66.7% over the past year.

Latest monthly visits90 3-month web change-70% 1-year team growth-66.7%

Monthly website visitsJul 2022–Jul 2025

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
WEWearLinqWearLinq is a provider of digital healthcare solutions with a focus on ambulatory electrocardiogram (ECG) monitoring	San Francisco, United States	Operational	51	$15M	$56M
ATATsensLong-term, wearable ECG monitoring patch and software	Seongnam-si, South Korea	Operational
LDLaxmi Therapeutic DevicesCreating the next generation of wearable diagnostic devices to help people living with Type I diabetes manage their lives smoothly	Goleta, United States	Operational
SHSibel HealthDevelops a neonatal epidermal system designed for wireless vital signs monitoring	Evanston, United States	Operational
BIBiometryBiomarker-driven asthma management with patented sensors for personalized risk assessment and guideline-based self-management	Boston, United States	Operational
CMCerca MagneticsDevelops a fully integrated wearable brain scanner using optically-pumped magnetometers, enhancing usability and performance without the need for cryogenic sensors	Maidstone, United Kingdom	Operational
HEHeruDeveloping an artificial intelligence (AI) driven vision diagnostics and augmentation platform designed to provide real-time diagnoses and personalized vision correction with the use of a wearable devices	Miami, United States	Operational
QOQuantum OperationWearable sensor for non-invasive, continuous glucose monitoring	Tokyo, Japan	Operational